Information  X 
Enter a valid email address

abrdn Asia Focus plc (AAS)

  Print          Annual reports

Wednesday 15 June, 2022

abrdn Asia Focus plc

New Director Appointment

RNS Number : 9591O
abrdn Asia Focus plc
15 June 2022

abrdn Asia Focus plc (the "Company")

Legal Entity Identifier (LEI): 5493000FBZP1J92OQY70


15 June 2022


Directorate Update


Appointment of Lindsay Cooper to the Board


The Board of abrdn Asia Focus plc is pleased to announce the appointment of Mr Lindsay Cooper as an independent non-executive Director of the Company with effect from 15 June 2022. Mr Cooper is a Singapore permanent resident and member of the Institute of Chartered Accountants of Scotland.  After working in corporate finance in Hong Kong in the early 1990's, Lindsay co-founded Arisaig Partners in 1996, an independent Investment Management business where, for 20 years, he had investment responsibility for the USD3bn Arisaig Asia Consumer Fund. Following semi-retirement Lindsay founded Chic & Unique Pte Ltd, a boutique hotels and hospitality business with operations in Asia and Europe and, more recently, founded Chi Tree Health, a preventative healthcare enterprise in Singapore. Mr Cooper is also closely involved with two charities: representing Singapore on the Magic Bus Global Board; and as a non-executive director on the board of Angkor Hospital for Children (AHC) in Siem Reap, Cambodia.


Nigel Cayzer, Chairman, commented:


"As part of our ongoing succession plans, on behalf of the Board I am delighted to welcome Lindsay to the Board.  Lindsay brings a significant amount of Asian investment and small cap expertise to the Board and, being based in Singapore, is perfectly placed to assist in overseeing the execution of the Company's expanded investment mandate that was approved by shareholders in January 2022."


In accordance with Listing Rule 9.6.13 (1):


Mr Cooper is not currently a director of any publicly listed companies and has not in the last five years been a director of any publicly listed companies.


Mr Cooper does not have a beneficial interest in any Ordinary shares of the Company.


In relation to Mr Cooper's appointment, there is no additional information required to be disclosed in accordance with Listing Rules 9.6.13 (2) - (6).


For further information, please contact:


Charles Mearns

Aberdeen Asset Management PLC


Tel. 0131 528 4132

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t